nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP2D6—Sorafenib—liver cancer	0.0463	0.38	CbGbCtD
Rivastigmine—CYP3A4—Sorafenib—liver cancer	0.0294	0.242	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—liver cancer	0.0281	0.231	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—liver cancer	0.0179	0.147	CbGbCtD
Rivastigmine—Hypokalaemia—Epirubicin—liver cancer	0.000815	0.00104	CcSEcCtD
Rivastigmine—Diarrhoea—Sorafenib—liver cancer	0.000815	0.00104	CcSEcCtD
Rivastigmine—Breast disorder—Epirubicin—liver cancer	0.00081	0.00104	CcSEcCtD
Rivastigmine—Nasopharyngitis—Epirubicin—liver cancer	0.000801	0.00103	CcSEcCtD
Rivastigmine—Face oedema—Doxorubicin—liver cancer	0.0008	0.00102	CcSEcCtD
Rivastigmine—Gastritis—Epirubicin—liver cancer	0.000793	0.00102	CcSEcCtD
Rivastigmine—Muscular weakness—Epirubicin—liver cancer	0.00079	0.00101	CcSEcCtD
Rivastigmine—Cardiac arrest—Doxorubicin—liver cancer	0.000788	0.00101	CcSEcCtD
Rivastigmine—Dizziness—Sorafenib—liver cancer	0.000788	0.00101	CcSEcCtD
Rivastigmine—Mood swings—Doxorubicin—liver cancer	0.000785	0.00101	CcSEcCtD
Rivastigmine—Ataxia—Doxorubicin—liver cancer	0.00078	0.000998	CcSEcCtD
Rivastigmine—Dysphagia—Epirubicin—liver cancer	0.000774	0.000991	CcSEcCtD
Rivastigmine—Dehydration—Doxorubicin—liver cancer	0.000771	0.000987	CcSEcCtD
Rivastigmine—Liver function test abnormal—Doxorubicin—liver cancer	0.000765	0.00098	CcSEcCtD
Rivastigmine—Dry skin—Doxorubicin—liver cancer	0.00076	0.000973	CcSEcCtD
Rivastigmine—Pancreatitis—Epirubicin—liver cancer	0.000759	0.000972	CcSEcCtD
Rivastigmine—Vomiting—Sorafenib—liver cancer	0.000758	0.00097	CcSEcCtD
Rivastigmine—Abdominal pain upper—Doxorubicin—liver cancer	0.000757	0.000969	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000757	0.000969	CcSEcCtD
Rivastigmine—Hypokalaemia—Doxorubicin—liver cancer	0.000754	0.000966	CcSEcCtD
Rivastigmine—Angina pectoris—Epirubicin—liver cancer	0.000754	0.000966	CcSEcCtD
Rivastigmine—Rash—Sorafenib—liver cancer	0.000751	0.000962	CcSEcCtD
Rivastigmine—Dermatitis—Sorafenib—liver cancer	0.000751	0.000961	CcSEcCtD
Rivastigmine—Breast disorder—Doxorubicin—liver cancer	0.000749	0.000959	CcSEcCtD
Rivastigmine—Headache—Sorafenib—liver cancer	0.000746	0.000956	CcSEcCtD
Rivastigmine—Bronchitis—Epirubicin—liver cancer	0.000745	0.000953	CcSEcCtD
Rivastigmine—Nasopharyngitis—Doxorubicin—liver cancer	0.000741	0.000949	CcSEcCtD
Rivastigmine—Gastritis—Doxorubicin—liver cancer	0.000734	0.000939	CcSEcCtD
Rivastigmine—Muscular weakness—Doxorubicin—liver cancer	0.000731	0.000936	CcSEcCtD
Rivastigmine—Dysuria—Epirubicin—liver cancer	0.000724	0.000927	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Epirubicin—liver cancer	0.00072	0.000921	CcSEcCtD
Rivastigmine—Dysphagia—Doxorubicin—liver cancer	0.000717	0.000917	CcSEcCtD
Rivastigmine—Pollakiuria—Epirubicin—liver cancer	0.000715	0.000916	CcSEcCtD
Rivastigmine—Nausea—Sorafenib—liver cancer	0.000708	0.000906	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Epirubicin—liver cancer	0.000707	0.000905	CcSEcCtD
Rivastigmine—Weight increased—Epirubicin—liver cancer	0.000705	0.000902	CcSEcCtD
Rivastigmine—Pancreatitis—Doxorubicin—liver cancer	0.000702	0.000899	CcSEcCtD
Rivastigmine—Weight decreased—Epirubicin—liver cancer	0.000701	0.000897	CcSEcCtD
Rivastigmine—Hyperglycaemia—Epirubicin—liver cancer	0.000699	0.000894	CcSEcCtD
Rivastigmine—Angina pectoris—Doxorubicin—liver cancer	0.000698	0.000893	CcSEcCtD
Rivastigmine—Pneumonia—Epirubicin—liver cancer	0.000694	0.000889	CcSEcCtD
Rivastigmine—Drowsiness—Epirubicin—liver cancer	0.00069	0.000884	CcSEcCtD
Rivastigmine—Infestation—Epirubicin—liver cancer	0.00069	0.000884	CcSEcCtD
Rivastigmine—Infestation NOS—Epirubicin—liver cancer	0.00069	0.000884	CcSEcCtD
Rivastigmine—Bronchitis—Doxorubicin—liver cancer	0.000689	0.000882	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000685	0.000876	CcSEcCtD
Rivastigmine—Renal failure—Epirubicin—liver cancer	0.000679	0.000869	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Epirubicin—liver cancer	0.000677	0.000866	CcSEcCtD
Rivastigmine—Urinary tract infection—Epirubicin—liver cancer	0.000671	0.000859	CcSEcCtD
Rivastigmine—Conjunctivitis—Epirubicin—liver cancer	0.000671	0.000859	CcSEcCtD
Rivastigmine—Dysuria—Doxorubicin—liver cancer	0.00067	0.000858	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000666	0.000852	CcSEcCtD
Rivastigmine—Sweating—Epirubicin—liver cancer	0.000662	0.000847	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—liver cancer	0.000662	0.000847	CcSEcCtD
Rivastigmine—Haematuria—Epirubicin—liver cancer	0.000658	0.000843	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000654	0.000837	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Epirubicin—liver cancer	0.000653	0.000836	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—liver cancer	0.000652	0.000835	CcSEcCtD
Rivastigmine—Epistaxis—Epirubicin—liver cancer	0.000651	0.000834	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—liver cancer	0.000648	0.00083	CcSEcCtD
Rivastigmine—Sinusitis—Epirubicin—liver cancer	0.000648	0.000829	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—liver cancer	0.000646	0.000827	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—liver cancer	0.000643	0.000823	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—liver cancer	0.000639	0.000818	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—liver cancer	0.000639	0.000818	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—liver cancer	0.000639	0.000818	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000633	0.000811	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—liver cancer	0.000631	0.000808	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—liver cancer	0.000628	0.000804	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000626	0.000802	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—liver cancer	0.000623	0.000798	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—liver cancer	0.000621	0.000795	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—liver cancer	0.000621	0.000795	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—liver cancer	0.000621	0.000795	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—liver cancer	0.00062	0.000793	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—liver cancer	0.00062	0.000793	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—liver cancer	0.000617	0.000789	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—liver cancer	0.000615	0.000788	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—liver cancer	0.000612	0.000784	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—liver cancer	0.000612	0.000784	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—liver cancer	0.000611	0.000782	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—liver cancer	0.000609	0.00078	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—liver cancer	0.000609	0.00078	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—liver cancer	0.000608	0.000778	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000604	0.000773	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—liver cancer	0.000603	0.000771	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—liver cancer	0.000599	0.000767	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—liver cancer	0.000597	0.000765	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—liver cancer	0.000586	0.00075	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—liver cancer	0.000584	0.000747	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—liver cancer	0.000579	0.000742	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—liver cancer	0.000578	0.00074	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—liver cancer	0.000576	0.000738	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—liver cancer	0.000575	0.000736	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—liver cancer	0.000575	0.000736	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—liver cancer	0.000575	0.000736	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—liver cancer	0.000574	0.000734	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—liver cancer	0.000574	0.000734	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—liver cancer	0.000571	0.00073	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—liver cancer	0.000569	0.000729	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—liver cancer	0.000566	0.000725	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—liver cancer	0.000565	0.000723	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—liver cancer	0.000564	0.000721	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—liver cancer	0.000562	0.00072	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—liver cancer	0.000562	0.00072	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—liver cancer	0.000559	0.000715	CcSEcCtD
Rivastigmine—Chills—Epirubicin—liver cancer	0.000556	0.000712	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—liver cancer	0.000554	0.000709	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—liver cancer	0.000553	0.000708	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—liver cancer	0.000548	0.000701	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—liver cancer	0.000543	0.000695	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—liver cancer	0.000542	0.000694	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—liver cancer	0.00054	0.000691	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—liver cancer	0.00054	0.000691	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—liver cancer	0.000536	0.000686	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—liver cancer	0.000535	0.000685	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—liver cancer	0.000532	0.000681	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—liver cancer	0.000532	0.000681	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—liver cancer	0.000532	0.000681	CcSEcCtD
Rivastigmine—Tension—Epirubicin—liver cancer	0.000529	0.000678	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—liver cancer	0.000528	0.000676	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—liver cancer	0.000524	0.000671	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—liver cancer	0.000522	0.000668	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—liver cancer	0.00052	0.000666	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—liver cancer	0.000519	0.000664	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—liver cancer	0.000517	0.000662	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—liver cancer	0.000515	0.000659	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—liver cancer	0.000512	0.000656	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—liver cancer	0.000509	0.000651	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—liver cancer	0.000507	0.000649	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—liver cancer	0.000502	0.000643	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—liver cancer	0.000501	0.000641	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—liver cancer	0.000499	0.000639	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—liver cancer	0.000499	0.000639	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—liver cancer	0.000499	0.000638	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—liver cancer	0.000496	0.000635	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—liver cancer	0.000492	0.00063	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—liver cancer	0.00049	0.000627	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—liver cancer	0.000489	0.000626	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—liver cancer	0.000487	0.000623	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—liver cancer	0.000485	0.000621	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—liver cancer	0.000485	0.000621	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—liver cancer	0.000484	0.000619	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—liver cancer	0.000483	0.000618	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—liver cancer	0.00048	0.000614	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—liver cancer	0.000477	0.00061	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—liver cancer	0.000474	0.000607	CcSEcCtD
Rivastigmine—Cough—Epirubicin—liver cancer	0.000471	0.000603	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—liver cancer	0.000471	0.000602	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—liver cancer	0.000467	0.000598	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—liver cancer	0.000466	0.000596	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—liver cancer	0.000463	0.000593	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—liver cancer	0.000461	0.000591	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—liver cancer	0.000459	0.000588	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—liver cancer	0.000459	0.000588	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—liver cancer	0.000459	0.000588	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—liver cancer	0.000459	0.000587	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—liver cancer	0.000458	0.000586	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000456	0.000584	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—liver cancer	0.000454	0.000581	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—liver cancer	0.00045	0.000576	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—liver cancer	0.000449	0.000575	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—liver cancer	0.000449	0.000574	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—liver cancer	0.000448	0.000573	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—liver cancer	0.000444	0.000568	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—liver cancer	0.000441	0.000565	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—liver cancer	0.00044	0.000564	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—liver cancer	0.000439	0.000562	CcSEcCtD
Rivastigmine—Infection—Epirubicin—liver cancer	0.000437	0.00056	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—liver cancer	0.000436	0.000558	CcSEcCtD
Rivastigmine—Shock—Epirubicin—liver cancer	0.000433	0.000555	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—liver cancer	0.000433	0.000554	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—liver cancer	0.000432	0.000553	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—liver cancer	0.000431	0.000552	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—liver cancer	0.000431	0.000552	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—liver cancer	0.00043	0.00055	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—liver cancer	0.000428	0.000548	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—liver cancer	0.000426	0.000545	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—liver cancer	0.000425	0.000544	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—liver cancer	0.000425	0.000544	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—liver cancer	0.000425	0.000544	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—liver cancer	0.000424	0.000542	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000422	0.00054	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—liver cancer	0.00042	0.000538	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—liver cancer	0.00042	0.000537	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—liver cancer	0.000416	0.000532	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—liver cancer	0.000411	0.000527	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—liver cancer	0.000411	0.000526	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—liver cancer	0.000407	0.000522	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—liver cancer	0.000405	0.000518	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000401	0.000514	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—liver cancer	0.000401	0.000513	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—liver cancer	0.0004	0.000512	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—liver cancer	0.000399	0.000511	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—liver cancer	0.000398	0.00051	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—liver cancer	0.000398	0.000509	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—liver cancer	0.000396	0.000507	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—liver cancer	0.000395	0.000506	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—liver cancer	0.000394	0.000504	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—liver cancer	0.000393	0.000503	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—liver cancer	0.000391	0.000501	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—liver cancer	0.000388	0.000497	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—liver cancer	0.000388	0.000496	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—liver cancer	0.000383	0.00049	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—liver cancer	0.000381	0.000487	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00038	0.000487	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—liver cancer	0.00038	0.000486	CcSEcCtD
Rivastigmine—Pain—Epirubicin—liver cancer	0.000377	0.000482	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—liver cancer	0.000377	0.000482	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000371	0.000475	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—liver cancer	0.000369	0.000472	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—liver cancer	0.000366	0.000468	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—liver cancer	0.000363	0.000465	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—liver cancer	0.000363	0.000465	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—liver cancer	0.000362	0.000464	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—liver cancer	0.00036	0.000461	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—liver cancer	0.000359	0.000459	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—liver cancer	0.000354	0.000453	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000352	0.00045	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—liver cancer	0.000351	0.00045	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—liver cancer	0.00035	0.000448	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—liver cancer	0.000348	0.000446	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—liver cancer	0.000348	0.000446	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—liver cancer	0.000348	0.000446	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—liver cancer	0.000348	0.000446	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—liver cancer	0.000336	0.00043	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000333	0.000427	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—liver cancer	0.000324	0.000415	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—liver cancer	0.000324	0.000414	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—liver cancer	0.000322	0.000412	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—liver cancer	0.000322	0.000412	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—liver cancer	0.000316	0.000404	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—liver cancer	0.000312	0.000399	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—liver cancer	0.000301	0.000386	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—liver cancer	0.0003	0.000384	CcSEcCtD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000298	0.00307	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000295	0.00304	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—NAT2—liver cancer	0.000294	0.00303	CbGpPWpGaD
Rivastigmine—Asthenia—Doxorubicin—liver cancer	0.000292	0.000374	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—liver cancer	0.000291	0.000373	CcSEcCtD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000291	0.003	CbGpPWpGaD
Rivastigmine—Pruritus—Doxorubicin—liver cancer	0.000288	0.000369	CcSEcCtD
Rivastigmine—BCHE—Peptide hormone metabolism—CTNNB1—liver cancer	0.000284	0.00292	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CG—liver cancer	0.000284	0.00292	CbGpPWpGaD
Rivastigmine—Vomiting—Epirubicin—liver cancer	0.00028	0.000358	CcSEcCtD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CD—liver cancer	0.000279	0.00288	CbGpPWpGaD
Rivastigmine—Diarrhoea—Doxorubicin—liver cancer	0.000279	0.000357	CcSEcCtD
Rivastigmine—Rash—Epirubicin—liver cancer	0.000278	0.000355	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—liver cancer	0.000277	0.000355	CcSEcCtD
Rivastigmine—Headache—Epirubicin—liver cancer	0.000276	0.000353	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—liver cancer	0.000269	0.000345	CcSEcCtD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000264	0.00272	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000263	0.00271	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000262	0.0027	CbGpPWpGaD
Rivastigmine—Nausea—Epirubicin—liver cancer	0.000262	0.000335	CcSEcCtD
Rivastigmine—ACHE—ATF-2 transcription factor network—IL6—liver cancer	0.000259	0.00267	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000259	0.00267	CbGpPWpGaD
Rivastigmine—Vomiting—Doxorubicin—liver cancer	0.000259	0.000332	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—liver cancer	0.000257	0.000329	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—liver cancer	0.000257	0.000329	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—liver cancer	0.000255	0.000327	CcSEcCtD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000255	0.00263	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—UGDH—liver cancer	0.000254	0.00262	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000252	0.0026	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GPX3—liver cancer	0.00025	0.00257	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CD—liver cancer	0.000249	0.00257	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000245	0.00252	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CB—liver cancer	0.000244	0.00251	CbGpPWpGaD
Rivastigmine—Nausea—Doxorubicin—liver cancer	0.000242	0.00031	CcSEcCtD
Rivastigmine—ACHE—Metabolism—EPT1—liver cancer	0.000239	0.00246	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000239	0.00246	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—HPGDS—liver cancer	0.000238	0.00245	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000233	0.0024	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000229	0.00236	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000228	0.00235	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—UGDH—liver cancer	0.000227	0.00234	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TAT—liver cancer	0.000227	0.00234	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000226	0.00233	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000223	0.0023	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.000222	0.00229	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CB—liver cancer	0.000217	0.00224	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—EPT1—liver cancer	0.000213	0.0022	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000212	0.00218	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.00021	0.00216	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000209	0.00215	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000207	0.00213	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000204	0.0021	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ATF3—liver cancer	0.000204	0.0021	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TAT—liver cancer	0.000202	0.00208	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000199	0.00205	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—BRAF—liver cancer	0.000198	0.00204	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000197	0.00203	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000195	0.00201	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP2E1—liver cancer	0.000194	0.002	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000192	0.00198	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000192	0.00198	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP2E1—liver cancer	0.000192	0.00197	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.000185	0.00191	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ATF3—liver cancer	0.000182	0.00187	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GGT1—liver cancer	0.000178	0.00184	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000176	0.00182	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000173	0.00178	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000172	0.00177	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—BRAF—liver cancer	0.00017	0.00175	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000168	0.00173	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000168	0.00173	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000167	0.00172	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000167	0.00172	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—RAF1—liver cancer	0.000165	0.0017	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000163	0.00168	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000163	0.00168	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTP1—liver cancer	0.00016	0.00165	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000159	0.00164	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTP1—liver cancer	0.000158	0.00163	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000156	0.0016	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CPT1B—liver cancer	0.000154	0.00159	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GLUL—liver cancer	0.000154	0.00159	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—BRAF—liver cancer	0.000152	0.00156	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000149	0.00153	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NR1H4—liver cancer	0.000149	0.00153	CbGpPWpGaD
Rivastigmine—ACHE—Phospholipid metabolism—PIK3CA—liver cancer	0.000148	0.00153	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000147	0.00152	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000147	0.00151	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTA3—liver cancer	0.000146	0.00151	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000145	0.0015	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—RAF1—liver cancer	0.000142	0.00146	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.00014	0.00144	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000138	0.00142	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CPT1B—liver cancer	0.000138	0.00142	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GLUL—liver cancer	0.000138	0.00142	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000135	0.00139	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000135	0.00139	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTA4—liver cancer	0.000134	0.00138	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NR1H4—liver cancer	0.000133	0.00137	CbGpPWpGaD
Rivastigmine—BCHE—Phospholipid metabolism—PIK3CA—liver cancer	0.000132	0.00136	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000131	0.00135	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA3—liver cancer	0.00013	0.00134	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTA2—liver cancer	0.00013	0.00134	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000127	0.00131	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—RAF1—liver cancer	0.000127	0.00131	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF2—liver cancer	0.000126	0.0013	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTA1—liver cancer	0.000126	0.00129	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000126	0.00129	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000125	0.00129	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000125	0.00128	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NAT2—liver cancer	0.000124	0.00128	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00012	0.00123	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA4—liver cancer	0.000119	0.00123	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALDOB—liver cancer	0.000119	0.00123	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000117	0.0012	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000117	0.0012	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA2—liver cancer	0.000116	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000114	0.00118	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CRABP1—liver cancer	0.000114	0.00117	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF2—liver cancer	0.000113	0.00116	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA1—liver cancer	0.000112	0.00116	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NAT2—liver cancer	0.000111	0.00114	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000111	0.00114	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000107	0.0011	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALDOB—liver cancer	0.000106	0.00109	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000105	0.00108	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—UGDH—liver cancer	0.000104	0.00108	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000103	0.00106	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000102	0.00105	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—HRAS—liver cancer	0.000102	0.00105	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CRABP1—liver cancer	0.000101	0.00104	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HPGDS—liver cancer	9.94e-05	0.00102	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.88e-05	0.00102	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—EPT1—liver cancer	9.81e-05	0.00101	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTM1—liver cancer	9.63e-05	0.000992	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	9.49e-05	0.000978	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	9.35e-05	0.000963	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TAT—liver cancer	9.3e-05	0.000958	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—F2—liver cancer	9.24e-05	0.000952	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	9.13e-05	0.00094	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	9.13e-05	0.00094	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—HRAS—liver cancer	9.11e-05	0.000938	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	9e-05	0.000927	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9e-05	0.000927	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.88e-05	0.000915	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HPGDS—liver cancer	8.86e-05	0.000913	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PSMA4—liver cancer	8.86e-05	0.000912	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PSMD10—liver cancer	8.86e-05	0.000912	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.81e-05	0.000908	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GOT2—liver cancer	8.61e-05	0.000887	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—F2—liver cancer	8.24e-05	0.000849	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2E1—liver cancer	8.1e-05	0.000834	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	8.03e-05	0.000827	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.92e-05	0.000816	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PSMA4—liver cancer	7.9e-05	0.000814	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PSMD10—liver cancer	7.9e-05	0.000814	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.84e-05	0.000808	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—MMP2—liver cancer	7.84e-05	0.000807	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—HRAS—liver cancer	7.82e-05	0.000806	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GOT2—liver cancer	7.69e-05	0.000792	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYCS—liver cancer	7.58e-05	0.000781	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GOT1—liver cancer	7.44e-05	0.000766	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GGT1—liver cancer	7.44e-05	0.000766	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2E1—liver cancer	7.23e-05	0.000744	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7e-05	0.000721	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—MMP2—liver cancer	6.99e-05	0.00072	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—HRAS—liver cancer	6.98e-05	0.000719	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—UGDH—liver cancer	6.83e-05	0.000703	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYCS—liver cancer	6.76e-05	0.000696	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTP1—liver cancer	6.68e-05	0.000688	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GOT1—liver cancer	6.63e-05	0.000683	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GGT1—liver cancer	6.63e-05	0.000683	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HMOX1—liver cancer	6.59e-05	0.000679	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—EPT1—liver cancer	6.42e-05	0.000661	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CPT1B—liver cancer	6.32e-05	0.000651	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GLUL—liver cancer	6.32e-05	0.000651	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTM1—liver cancer	6.14e-05	0.000632	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NR1H4—liver cancer	6.1e-05	0.000628	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TAT—liver cancer	6.08e-05	0.000627	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—CTNNB1—liver cancer	6.01e-05	0.000619	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA3—liver cancer	6e-05	0.000618	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTP1—liver cancer	5.96e-05	0.000614	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HMOX1—liver cancer	5.88e-05	0.000605	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP1A1—liver cancer	5.82e-05	0.000599	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA4—liver cancer	5.48e-05	0.000565	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTM1—liver cancer	5.48e-05	0.000564	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTHFR—liver cancer	5.43e-05	0.000559	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—CTNNB1—liver cancer	5.36e-05	0.000552	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA2—liver cancer	5.34e-05	0.00055	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARA—liver cancer	5.32e-05	0.000548	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP1A1—liver cancer	5.19e-05	0.000535	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA1—liver cancer	5.16e-05	0.000531	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NAT2—liver cancer	5.1e-05	0.000525	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALDOB—liver cancer	4.89e-05	0.000503	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTHFR—liver cancer	4.84e-05	0.000499	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.78e-05	0.000492	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARA—liver cancer	4.75e-05	0.000489	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CRABP1—liver cancer	4.66e-05	0.00048	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CG—liver cancer	4.56e-05	0.000469	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PPARG—liver cancer	4.4e-05	0.000453	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.26e-05	0.000439	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GLUL—liver cancer	4.14e-05	0.000426	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CPT1B—liver cancer	4.14e-05	0.000426	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HPGDS—liver cancer	4.08e-05	0.00042	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CG—liver cancer	4.07e-05	0.000419	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CD—liver cancer	4.01e-05	0.000413	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NR1H4—liver cancer	3.99e-05	0.000411	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ALB—liver cancer	3.96e-05	0.000407	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PPARG—liver cancer	3.92e-05	0.000404	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA3—liver cancer	3.92e-05	0.000404	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PSMA4—liver cancer	3.63e-05	0.000374	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PSMD10—liver cancer	3.63e-05	0.000374	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA4—liver cancer	3.59e-05	0.000369	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CD—liver cancer	3.57e-05	0.000368	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GOT2—liver cancer	3.53e-05	0.000364	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ALB—liver cancer	3.53e-05	0.000363	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA2—liver cancer	3.49e-05	0.00036	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CB—liver cancer	3.49e-05	0.00036	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA1—liver cancer	3.37e-05	0.000347	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NAT2—liver cancer	3.33e-05	0.000343	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2E1—liver cancer	3.32e-05	0.000342	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALDOB—liver cancer	3.2e-05	0.000329	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CB—liver cancer	3.12e-05	0.000321	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYCS—liver cancer	3.11e-05	0.00032	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GGT1—liver cancer	3.05e-05	0.000314	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GOT1—liver cancer	3.05e-05	0.000314	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CRABP1—liver cancer	3.05e-05	0.000314	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—liver cancer	2.74e-05	0.000282	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HMOX1—liver cancer	2.7e-05	0.000278	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HPGDS—liver cancer	2.66e-05	0.000274	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM1—liver cancer	2.52e-05	0.000259	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.39e-05	0.000246	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSMA4—liver cancer	2.37e-05	0.000245	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PSMD10—liver cancer	2.37e-05	0.000245	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GOT2—liver cancer	2.31e-05	0.000238	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTHFR—liver cancer	2.23e-05	0.000229	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARA—liver cancer	2.18e-05	0.000225	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.17e-05	0.000224	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PIK3CA—liver cancer	2.13e-05	0.000219	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYCS—liver cancer	2.03e-05	0.000209	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GGT1—liver cancer	1.99e-05	0.000205	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GOT1—liver cancer	1.99e-05	0.000205	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PIK3CA—liver cancer	1.9e-05	0.000196	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.87e-05	0.000193	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PPARG—liver cancer	1.8e-05	0.000186	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—liver cancer	1.79e-05	0.000185	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HMOX1—liver cancer	1.77e-05	0.000182	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—AKT1—liver cancer	1.74e-05	0.000179	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM1—liver cancer	1.65e-05	0.00017	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.64e-05	0.000169	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ALB—liver cancer	1.62e-05	0.000167	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.56e-05	0.000161	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—AKT1—liver cancer	1.55e-05	0.00016	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTHFR—liver cancer	1.45e-05	0.00015	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.43e-05	0.000148	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARA—liver cancer	1.43e-05	0.000147	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.22e-05	0.000126	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PPARG—liver cancer	1.18e-05	0.000122	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.07e-05	0.000111	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ALB—liver cancer	1.06e-05	0.000109	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CB—liver cancer	9.37e-06	9.65e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PIK3CA—liver cancer	8.73e-06	9e-05	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—AKT1—liver cancer	7.13e-06	7.35e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PIK3CA—liver cancer	5.71e-06	5.88e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—AKT1—liver cancer	4.66e-06	4.8e-05	CbGpPWpGaD
